Skip to content
Coronavirus (COVID-19): Testing & Vaccines

NOVO NORDISK “ONWARDS4”

30th April, 2021 | Published by Saltzer Health

research

NOVO NORDISK “ONWARDS4”

ONWARDS is a global programme of clinical studies to investigate how well an investigation insulin taken once weekly, insulin icodec, controls blood sugar in people with diabetes. Once-weekly insulin icodec will be compared with insulins taken once daily, which are already available on the market

Request to participate in research study.

Research Participation Form

"*" indicates required fields

Name*
Terms & Conditions*
I understand my information is kept confidential in the NWCT patient database and will not be shared with any third parties. If you do not wish for your information to be kept, please ask the recruiter to remove you from our patient database.
This field is for validation purposes and should be left unchanged.